MoonLake Immunotherapeutics (MLTX)

$51.34 -$2.78 (-5.18%) 10:56 PM 12/14/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $3.24B

  • Day's Range

    $50.62 - $54.03

  • Volume

    158,413

  • 52 Week Low / High

    $37.55 - $64.98

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

MLTX's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
11
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
$63.27
Target Price

Company News

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now? — Sep 25th, 2024

    We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where MoonLake Immunotherapeutics (NASDAQ:MLTX) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that ...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

  • Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now? — Sep 25th, 2024

    We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where MoonLake Immunotherapeutics (NASDAQ:MLTX) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that ...

  • Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024

    Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free